In Pursuit of Individualised Margins for Prostate Cancer Patients Undergoing Image-guided Radiotherapy: The Effect of Body Mass Index on Intrafraction Prostate Motion

Clinical Oncology

Volumn 23, Issue 7, 2011, Pages 449-453

  Thompson, A L ^a   Gill, S ^a   Thomas, J ^a   Kron, T ^a   Fox, C ^a   Herschtal, A ^a   Tai, K H ^a,b   Foroudi, F ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Body mass index; IGRT; Image guided radiotherapy; Obesity; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER PATIENT; CANCER RADIOTHERAPY; DISEASE SEVERITY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER;

ADOLESCENT; ADULT; BODY MASS INDEX; FIDUCIAL MARKERS; HUMANS; INDIVIDUALIZED MEDICINE; MALE; NEOPLASM STAGING; OBESITY; OVERWEIGHT; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RADIOTHERAPY, INTENSITY-MODULATED; YOUNG ADULT;

EID: 79960907908     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.01.511     Document Type: Article

References (24)

1. Health survey for England 2008: physical activity and fitness 2009, NHS Information Centre. R. Craig, J. Mindell, V. Hirani (Eds.).
2. Strom S.S., Kamat A.M., Gruschkus S.K., et al. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer 2006, 107:631-639.
3. Stroup S.P., Cullen J., Auge B.K., L'Esperance J.O., Kang S.K. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition. Cancer 2007, 110:1003-1009.
4. Merrick G.S., Butler W.M., Wallner K.E., et al. Influence of body mass index on biochemical outcome after permanent prostate brachytherapy. Urology 2005, 65:95-100.
5. Kupelian P.A., Langen K.M., Willoughby T.R., Zeidan O.A., Meeks S.L. Image-guided radiotherapy for localized prostate cancer: treating a moving target. Semin Radiat Oncol 2008, 18:58-66.
6. Schallenkamp J.M., Herman M.G., Kruse J.J., Pisansky T.M. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 2005, 63:800-811.
7. Foroudi F., Fox C. Prostate fiducials and margins. J Med Imaging Radiat Oncol 2008, 52:425-426.
8. van Herk M., Remeijer P., Rasch C., Lebesque J.V. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000, 47:1121-1135.
9. Wong J.R., Gao Z., Merrick S., et al. Potential for higher treatment failure in obese patients: correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocenters in an analysis of 1,465 computed tomographic images. Int J Radiat Oncol Biol Phys 2009, 75:49-55.
10. Millender L.E., Aubin M., Pouliot J., Shinohara K., Roach M. Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004, 59:6-10.
11. Thompson A., Fox C., Foroudi F., et al. Planning and implementing an implanted fiducial programme for prostate cancer radiation therapy. J Med Imaging Radiat Oncol 2008, 52:419-424.
12. Fox C., Fisher R., Kron T., et al. Extraction of data for margin calculations in prostate radiotherapy from a commercial record and verify system. J Med Imaging Radiat Oncol 2010, 54:161-170.
13. World Health Organization BMI classification. Available at: http://apps.who.int/bmi/index.jsp%3fintroPage%3dintro_3.html.
14. Adamson J., Wu Q. Inferences about prostate intrafraction motion from pre- and posttreatment volumetric imaging. Int J Radiat Oncol Biol Phys 2009, 75:260-267.
15. Padhani A.R., Khoo V.S., Suckling J., Husband J.E., Leach M.O., Dearnaley D.P. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys 1999, 44:525-533.
16. Ghilezan M.J., Jaffray D.A., Siewerdsen J.H., et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 2005, 62:406-417.
17. Vargas C., Saito A.I., Hsi W.C., et al. Cine-magnetic resonance imaging assessment of intrafraction motion for prostate cancer patients supine or prone with and without a rectal balloon. Am J Clin Oncol 2010, 33:11-16.
18. Mah D., Freedman G., Milestone B., et al. Measurement of intrafractional prostate motion using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2002, 54:568-575.
19. Nichol A.M., Warde P.R., Lockwood G.A., et al. A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion. Int J Radiat Oncol Biol Phys 2010, 77:1072-1078.
20. Willoughby T.R., Kupelian P.A., Pouliot J., et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 2006, 65:528-534.
21. Langen K.M., Willoughby T.R., Meeks S.L., et al. Observations on real-time prostate gland motion using electromagnetic tracking. Int J Radiat Oncol Biol Phys 2008, 71:1084-1090.
22. Kupelian P., Willoughby T., Mahadevan A., et al. Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67:1088-1098.
23. Noel C., Parikh P.J., Roy M., et al. Prediction of intrafraction prostate motion: accuracy of pre- and post-treatment imaging and intermittent imaging. Int J Radiat Oncol Biol Phys 2009, 73:692-698.
24. Kron T., Thomas J., Fox C., et al. Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers. Radiother Oncol 2010, 95:191-197.